Karen Wilson

2009

In 2009, Karen Wilson earned a total compensation of $344.7K as Former Vice President of Finance and Principal Accounting Officer at PDL BioPharma.

Compensation breakdown

Non-Equity Incentive Plan$59,358
Salary$173,296
Stock Awards$75,000
Other$37,053
Total$344,707

Wilson received $173.3K in salary, accounting for 50% of the total pay in 2009.

Wilson also received $59.4K in non-equity incentive plan, $75K in stock awards and $37.1K in other compensation.

Rankings

In 2009, Karen Wilson's compensation ranked 7,983rd out of 9,885 executives tracked by ExecPay. In other words, Wilson earned more than 19.2% of executives.

ClassificationRankingPercentile
All
7,983
out of 9,885
19th
Division
Manufacturing
2,995
out of 3,690
19th
Major group
Chemicals And Allied Products
687
out of 871
21st
Industry group
Drugs
496
out of 643
23rd
Industry
Biological Products, Except Diagnostic Substances
92
out of 138
33rd
Source: SEC filing on April 23, 2012.

Wilson's colleagues

We found three more compensation records of executives who worked with Karen Wilson at PDL BioPharma in 2009.

2009

John McLaughlin

PDL BioPharma

Chief Executive Officer

2009

Christine Larson

PDL BioPharma

Chief Financial Officer

2009

Christopher Stone

PDL BioPharma

General Counsel

You may also like